Preproinsulin Designer Antigens Excluded from Endoplasmic Reticulum Suppressed Diabetes Development in NOD Mice by DNA Vaccination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preproinsulin Designer Antigens Excluded from Endoplasmic Reticulum Suppressed Diabetes Development in NOD Mice by DNA Vaccination

Published:2019-03 Issue: Volume:12 Page:123-133
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Stifter Katja,Schuster Cornelia,Krieger Jana,Spyrantis Andreas,Boehm Bernhard Otto,Schirmbeck Reinhold

Funder

Deutsche Forschungsgemeinschaft

Lee Kong Chian School of Medicine

Nanyang Technological University Start Up Grant

Ministry of Education - Singapore (MOE)

OE AcRF Tier 1

MOE

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference56 articles.

1. DNA vaccines for autoimmune diseases;Garren;Expert Rev. Vaccines,2009

2. Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes;Johnson;Hum. Vaccin.,2011

3. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness;Harlan;Proc. Natl. Acad. Sci. USA,1994

4. Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice;Karges;Diabetes,2002

5. The diabetogenic, insulin-specific CD8 T cell response primed in the experimental autoimmune diabetes model in RIP-B7.1 mice;Karges;Eur. J. Immunol.,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leverage biomaterials to modulate immunity for type 1 diabetes;Frontiers in Immunology;2022-11-02

2. Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes;Proceedings of the National Academy of Sciences;2022-04-06

3. Preclinical evaluation of a precision medicine approach to DNA vaccination in Type 1 diabetes;2021-06-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3